Example: Heart Attack

Clinical Trials on Von Hippel-Lindau Disease

Total 38 results

NCT02108002

Completed

Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)

Conditions: Von Hippel-Lindau Disease
NCT02420067

Recruiting

Screening for Endolymphatic Sac Tumours (ELSTs) in Von Hippel-Lindau (vHL) Patients

Conditions: Von Hippel-Lindau Disease
NCT01168440

Completed

Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) Disease

Conditions: Von Hippel-Lindau Disease
NCT00062166

Completed

Natural History and Management of Pancreatic Lesions in Von Hippel-Lindau Disease

Conditions: Von Hippel-Lindau Disease
NCT02859441

Completed

A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab

Conditions: Von Hippel-Lindau Syndrome
NCT01015300

Terminated

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

Conditions: Hemangioblastomas; Von Hippel Lindau Disease
NCT00001803

Terminated

Von Hippel-Lindau Disease Genetic Epidemiology Study

Conditions: Von Hippel Lindau Disease; Kidney Neoplasms
NCT00673816

Terminated

Sunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome

Conditions: Von Hippel-Lindau Syndrome
NCT00056199

Completed

EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Conditions: Hippel-Lindau Disease
NCT01266070

Terminated

TKI 258 in Von Hippel-Lindau Syndrome (VHL)

Conditions: Von Hippel-Lindau Syndrome
NCT01436227

Active, not recruiting

Pazopanib Hydrochloride in Treating Patients With Von Hippel-Lindau Syndrome

Conditions: Von Hippel-Lindau Syndrome
NCT00052013

Completed

Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584

Conditions: Von Hippel-Lindau Disease; CNS Hemangioblastoma; Retinal Hemangioblastoma
NCT00089765

Completed

Ranibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Conditions: Von Hippel-Lindau Syndrome
NCT00088374

Completed

17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease

Conditions: Hippel-Lindau Disease; Kidney Cancer
NCT02207686

Unknown status

Assessment of Residual VHL Function in Tumors - Can it Predict the Patients' Individual Course of Disease?

Conditions: Von Hippel-Lindaus Disease
NCT03979833

Enrolling by invitation

Drivers of Hypoxia-induced Angiogenesis in Tumor Development

Conditions: Von Hippel-Lindau Disease
NCT00970970

Completed

Visualizing Vascular Endothelial Growth Factor (VEGF) Producing Lesions in Von Hippel-Lindau Disease

Conditions: Von Hippel-Lindau Disease; Hemangioblastoma; Renal Cell Carcinoma; Pheochromocytoma; Pancreatic Neuroendocrine Tumor
NCT03907657

Recruiting

Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau

Conditions: Von-Hippel Lindau; Kidney Disease, Chronic
NCT04074135

Recruiting

Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

Conditions: VHL Pancreatic Neuroendocrine Tumors; Von Hippel-Lindau Disease; Neuroendocrine Tumors
NCT03108066

Active, not recruiting

PT2385 for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma

Conditions: VHL Gene Mutation; VHL; VHL Syndrome; VHL Gene Inactivation; Von Hippel; Von Hippel-Lindau Disease; Von Hippel's Disease; Von Hippel-Lindau Syndrome, Modifiers of; Clear Cell Renal Cell Carcinoma; Clear Cell RCC; ccRCC
NCT00005902

Active, not recruiting

Study of Brain and Spinal Cord Tumor Growth and Cyst Development in Patients With Von Hippel Lindau Disease

Conditions: Hemangioblastoma; Hippel Lindau Disease
NCT00566995

Completed

Phase II Study of Vandetanib in Individuals With Kidney Cancer

Conditions: Renal Cancer; Von Hippel Lindau
NCT00330564

Terminated

Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow

Conditions: Von Hippel-Lindau Syndrome; Renal Cell Carcinoma; Hemangioblastoma
NCT04458935

Active, not recruiting

Retrospective Case Series of Trans-scleral Cryotherapy for Retinal Hemangioblastoma

Conditions: Retinal Hemangioblastoma; Von Hippel-Lindau Disease
NCT00075348

Completed

Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome

Conditions: Kidney Cancer; Von Hippel-lindau Syndrome